Cleared Traditional

K221373 - Essenz HLM

K221373 is an FDA 510(k) clearance for Essenz HLM, manufactured by Livanova Deutschland, GmbH. The device is a Class 2 Cardiovascular device with product code DTQ cleared through the Traditional 510(k) pathway after a 301-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
301d
Days
Class 2
Risk

K221373 is an FDA 510(k) clearance for the Essenz HLM. Classified as Console, Heart-lung Machine, Cardiopulmonary Bypass (product code DTQ), Class II - Special Controls.

Submitted by Livanova Deutschland, GmbH (Munich, DE). The FDA issued a Cleared decision on March 9, 2023 after a review of 301 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Livanova Deutschland, GmbH devices

FDA 510(k) Submission Details - K221373

510(k) Number K221373 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 12, 2022
Decision Date March 09, 2023
Days to Decision 301 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
176d slower than avg
Panel avg: 125d · This submission: 301d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DTQ Device Classification - Class 2, Special Controls

Product Code DTQ Console, Heart-lung Machine, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DTQ Console, Heart-lung Machine, Cardiopulmonary Bypass

All 26
Devices cleared under the same product code (DTQ) and FDA review panel - the closest regulatory comparables to K221373.
Essenz HLM, Essenz ILBM
K232291 · Livanova Deutschland, GmbH · Aug 2023
Terumo Advanced Perfusion System 1
K221895 · Terumo Cardiovascular Systems Corporation · Apr 2023
Stockert S5 System
K210130 · Livanova Deutschland, GmbH · Apr 2021
Century Perfusion System
K202125 · Century Hlm, LLC · Mar 2021
Quantum Smart Occluder LH (left-hand), Quantum Smart Occluder LH (right-hand)
K190282 · Spectrum Medical , Ltd. · May 2019
Quantum Pump Console
K173834 · Spectrum Medical , Ltd. · May 2018